208 related articles for article (PubMed ID: 28018354)
1. Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks.
Isernhagen A; Malzahn D; Bickeböller H; Dressel R
Front Immunol; 2016; 7():588. PubMed ID: 28018354
[TBL] [Abstract][Full Text] [Related]
2. The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.
Isernhagen A; Schilling D; Monecke S; Shah P; Elsner L; Walter L; Multhoff G; Dressel R
Immunogenetics; 2016 Feb; 68(2):109-23. PubMed ID: 26585323
[TBL] [Abstract][Full Text] [Related]
3. The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.
Isernhagen A; Malzahn D; Viktorova E; Elsner L; Monecke S; von Bonin F; Kilisch M; Wermuth JM; Walther N; Balavarca Y; Stahl-Hennig C; Engelke M; Walter L; Bickeböller H; Kube D; Wulf G; Dressel R
EMBO Mol Med; 2015 Nov; 7(11):1480-502. PubMed ID: 26483398
[TBL] [Abstract][Full Text] [Related]
4. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
Front Immunol; 2018; 9():926. PubMed ID: 29765374
[TBL] [Abstract][Full Text] [Related]
5. A Valine Mismatch at Position 129 of
Michita RT; Chies JAB; Schramm S; Horn PA; Heinemann FM; Wunsch A; Viebahn R; Schenker P; Rebmann V
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30181474
[TBL] [Abstract][Full Text] [Related]
6. Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population.
López-Hernández R; Valdés M; Lucas D; Campillo JA; Martínez-Garcia P; Salama H; López M; Salgado G; Botella C; Minguela A; Miras M; Alvarez-López MR; Carballo F; Muro M
Hum Immunol; 2010 May; 71(5):512-4. PubMed ID: 20152875
[TBL] [Abstract][Full Text] [Related]
7. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism.
Amroun H; Djoudi H; Busson M; Allat R; El Sherbini SM; Sloma I; Ramasawmy R; Brun M; Dulphy N; Krishnamoorthy R; Toubert A; Charron D; Abbadi MC; Tamouza R
Hum Immunol; 2005 Oct; 66(10):1057-61. PubMed ID: 16386647
[TBL] [Abstract][Full Text] [Related]
8. The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.
Rohn H; Tomoya Michita R; Schwich E; Dolff S; Gäckler A; Trilling M; Le-Trilling VTK; Wilde B; Korth J; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V
Front Immunol; 2018; 9():917. PubMed ID: 29867932
[TBL] [Abstract][Full Text] [Related]
9. MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk.
Ouni N; Ben Chaaben A; Kablouti G; Lajnef M; Ayari F; Abaza H; Damak T; Harzallah L; Benammar-Elgaaeid A; Guemira F; Tamouza R
Immunol Invest; 2017 Aug; 46(6):603-614. PubMed ID: 28742417
[TBL] [Abstract][Full Text] [Related]
10. Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation.
Baranwal AK; Mehra NK
Front Immunol; 2017; 8():182. PubMed ID: 28293239
[TBL] [Abstract][Full Text] [Related]
11. Role of the MICA polymorphism in systemic lupus erythematosus.
Yoshida K; Komai K; Shiozawa K; Mashida A; Horiuchi T; Tanaka Y; Nose M; Hashiramoto A; Shiozawa S
Arthritis Rheum; 2011 Oct; 63(10):3058-66. PubMed ID: 21702010
[TBL] [Abstract][Full Text] [Related]
12. Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis.
Iwaszko M; Świerkot J; Dratwa M; Wysoczańska B; Korman L; Bugaj B; Kolossa K; Jeka S; Wiland P; Bogunia-Kubik K
Pharmacogenomics J; 2020 Dec; 20(6):760-769. PubMed ID: 32123296
[TBL] [Abstract][Full Text] [Related]
13. Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease.
Boukouaci W; Al-Daccak R; Dulphy N; Lauden L; Amokrane K; Fortier C; Marzais F; Bennabi M; Peffault de Latour R; Socie G; Toubert A; Charron D; Krishnamoorthy R; Tamouza R
Hum Immunol; 2013 Dec; 74(12):1536-41. PubMed ID: 23994587
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
15. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population.
Douik H; Ben Chaaben A; Attia Romdhane N; Romdhane HB; Mamoghli T; Fortier C; Boukouaci W; Harzallah L; Ghanem A; Gritli S; Makni M; Charron D; Krishnamoorthy R; Guemira F; Tamouza R
Hum Immunol; 2009 Jan; 70(1):45-8. PubMed ID: 19000729
[TBL] [Abstract][Full Text] [Related]
16. Impact of donor NKG2D and MICA gene polymorphism on clinical outcomes of adult and paediatric allogeneic cord blood transplantation for malignant diseases.
Cox ST; Patterson W; Duggleby R; Jones OJR; Madrigal JA; Querol S; Salvador FR; Mata MJH; Volt F; Gluckman É; Szydlo R; Danby RD; Hernandez D
Eur J Haematol; 2024 Jul; 113(1):32-43. PubMed ID: 38511389
[TBL] [Abstract][Full Text] [Related]
17. MICA polymorphism: biology and importance in cancer.
Chen D; Gyllensten U
Carcinogenesis; 2014 Dec; 35(12):2633-42. PubMed ID: 25330802
[TBL] [Abstract][Full Text] [Related]
18. Diversity and characterization of polymorphic 5' promoter haplotypes of MICA and MICB genes.
Cox ST; Madrigal JA; Saudemont A
Tissue Antigens; 2014 Sep; 84(3):293-303. PubMed ID: 24962621
[TBL] [Abstract][Full Text] [Related]
19. MICA and NKG2D variants as risk factors in spondyloarthritis: a case-control study.
Fechtenbaum M; Desoutter J; Delvallez G; Brochot E; Guillaume N; Goëb V
Genes Immun; 2019 Sep; 20(7):599-605. PubMed ID: 30177859
[TBL] [Abstract][Full Text] [Related]
20. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells.
Bedel R; Thiery-Vuillemin A; Grandclement C; Balland J; Remy-Martin JP; Kantelip B; Pallandre JR; Pivot X; Ferrand C; Tiberghien P; Borg C
Cancer Res; 2011 Mar; 71(5):1615-26. PubMed ID: 21257710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
